Intensity is developing proprietary intratumoral immunotherapy products that both directly kill injected solid tumors AND induce immune system recognition of cancer cells throughout the body to address the three challenges of cancer treatment: local, regional, and metastatic disease.
Location: United States, Connecticut, Westport
Employees: 1-10
Total raised: $10M
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | VCapital | vcapital.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.06.2016 | Series A | $10M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 25.06.2021 | Roth Capital Partners to Host a Virtual Healthcare Private C... | NEWPORT BEACH, Calif., June 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Roth Capital Partners (... | marketscre... |
| 02.11.2018 | Intensity Therapeutics Raises $6.5 Million in Series B | WESTPORT, Conn., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc., a clinical-stage bi... | citybizlis... |
| 29.06.2016 | Intensity Therapeutics Nets $10M | WESTPORT, CT, Intensity Therapeutics, a privately held biotechnology company developing proprietar... | vcnewsdail... |
| 28.06.2016 | Biotechnology Company Intensity Therapeutics Secures $10M in... | Intensity Therapeutics, Inc., a Westport, CT-based biotechnology company developing proprietary canc... | finsmes.co... |
| 28.06.2016 | Intensity Therapeutics Raises $10 Million | WESTPORT, Conn.--(BUSINESS WIRE)--Intensity Therapeutics, Inc., a privately held biotechnology compa... | citybizlis... |